I agree that this site is using cookies. You can find further informations here.
X
Oekelen, Oliver Van
40  results:
Search for persons X
?
1

Pharmacodynamic changes in tumor and immune cells drive ibe..:

Amatangelo, Michael ; Flynt, Erin ; Stong, Nicholas...
Cell Reports Medicine.  5 (2024)  6 - p. 101571 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Iberdomide increases innate and adaptive immune cell subset..:

Van Oekelen, Oliver ; Amatangelo, Michael ; Guo, Manman...
Cell Reports Medicine.  5 (2024)  6 - p. 101584 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Interventions and outcomes of patients with multiple myelom..:

Van Oekelen, Oliver ; Nath, Karthik ; Mouhieddine, Tarek H....
Blood.  141 (2023)  7 - p. 756-765 , 2023
Link: https://doi.org/10.1182/..
 
?
4

Cellular mechanisms associated with sub-optimal immune resp..:

Aleman, Adolfo ; van Kesteren, Morgan ; Zajdman, Ariel Kogan...
eBioMedicine.  98 (2023)  - p. 104886 , 2023
Link: https://doi.org/10.1016/..
 
?
5

P-381 Mezigdomide (CC-92480) activates innate and adaptive ..:

Chen, Lucia ; Amatangelo, Michael ; van Oekelen, Oliver...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S250 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Sequencing T-cell redirection therapies leads to deep and d..:

Mouhieddine, Tarek H. ; Van Oekelen, Oliver ; Melnekoff, David T....
Blood Advances.  7 (2023)  6 - p. 1056-1064 , 2023
Link: https://doi.org/10.1182/..
 
?
7

P-175 Improving Anti-BCMA CAR-T functionality with novel im..:

Aleman, Adolfo ; Kogan-Zajdman, Ariel ; Upadhyaya, Bhaskar...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S131-S132 , 2023
Link: https://doi.org/10.1016/..
 
?
8

P-093: Iberdomide induces activation and proliferation of i..:

Van Oekelen, Oliver ; Amatangelo, Michael ; Guo, Manman...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S86-S87 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Poster: MM-530 Interventions and Outcomes of Multiple Myelo..:

Van Oekelen, Oliver ; Nath, Karthik ; Mouhieddine, Tarek H....
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S184 , 2022
Link: https://doi.org/10.1016/..
 
?
10

CD8+ T cells: An ineffective armor against prolonged COVID-..:

Van Oekelen, Oliver ; Parekh, Samir
Cell Reports Medicine.  3 (2022)  7 - p. 100695 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Multi-Omics Profiling of the Tumor Microenvironment:

, In: Advances in Experimental Medicine and Biology; Computational Methods for Precision Oncology,
Van Oekelen, Oliver ; Laganà, Alessandro - p. 283-326 , 2022
Link: https://doi.org/10.1007/..
 
?
12

P-065: Development of a mass cytometry-based toolkit to inv..:

Gooding, Sarah ; Guo, Manman ; Van Oekelen, Oliver...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S71 , 2022
Link: https://doi.org/10.1016/..
 
?
13

P-078: Targeted sequencing in a diverse real-world cohort o..:

Thibaud, Santiago ; Brander, tehilla ; Balwani, Manisha...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S78 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Characteristics of measurable residual disease assessment i..:

Van Oekelen, Oliver ; Birrer, Nicole ; Wesson, William...
Blood Cancer Journal.  12 (2022)  11 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
15

MM-530 Interventions and Outcomes of Multiple Myeloma Patie..:

Van Oekelen, Oliver ; Nath, Karthik ; Mouhieddine, Tarek H....
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S428 , 2022
Link: https://doi.org/10.1016/..
 
1-15